VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Adjusted EPS | ₹21.31 | ₹19.87 | ₹30.47 | ₹50.04 | ₹-8.10 |
What is the latest Earnings Per Share (EPS) of VENUS REMEDIES ?
Year | Earnings Per Share (EPS) |
---|---|
Mar2024 | ₹21.31 |
Mar2023 | ₹19.87 |
Mar2022 | ₹30.47 |
Mar2021 | ₹50.04 |
Mar2020 | ₹-8.10 |
How is Earnings Per Share (EPS) of VENUS REMEDIES Trending?
Years | Earnings Per Share (EPS) | % Change | |
---|---|---|---|
Mar2024 | ₹21.31 | 7.25 | |
Mar2023 | ₹19.87 | -34.79 | |
Mar2022 | ₹30.47 | -39.11 | |
Mar2021 | ₹50.04 | Positive | |
Mar2020 | ₹-8.10 | - |
Compare Earnings Per Share (EPS) of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹424.6 Cr | 6.5% | 2.1% | -21.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,544.0 Cr | 2.7% | -2.4% | 49.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,865.0 Cr | 2.9% | 6.2% | 64.2% | Stock Analytics | |
CIPLA | ₹123,920.0 Cr | 1% | 6.4% | 28.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,224.0 Cr | 1% | -2.3% | 6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,832.3 Cr | 2.4% | -1.1% | 53.4% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 6.5% |
2.1% |
-21.1% |
SENSEX | 1.1% |
1.1% |
22.2% |
You may also like the below Video Courses